Ambalal Sarabhai Enterprises Ltd
AMBALALSAAmbalal Sarabhai Enterprises Ltd
AMBALALSA
Price Chart
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 64.94 | 2.34 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 44.56 | 5.12 | 0.70% |
Forecast & Ratings
Detailed ForecastPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Ambalal Sarabhai Enterprises Limited is a manufacturer of formulations. It markets specialty pharmaceutical products under its three sub-divisions: oncology, infertility and uro-gynaec.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Mankind Pharma Ltd
Torrent Pharmaceuticals Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 137.55 | 226.99 | 140.37 | 150.24 | 159.60 | 157.89 | 203.33 | 245.19 | 182.77 | 168.69 | ||||||||||
Raw Materials | 72.07 | 71.25 | 77.06 | 71.33 | 90.28 | 81.51 | 98.39 | 114.07 | 105.24 | 153.96 | ||||||||||
| Power & Fuel Cost | 2.80 | 3.67 | 2.68 | 2.84 | 3.22 | 2.71 | 2.86 | 3.64 | 4.20 | |||||||||||
| Employee Cost | 28.47 | 31.29 | 28.71 | 26.67 | 26.02 | 27.06 | 28.17 | 25.27 | 25.24 | |||||||||||
| Selling & Administrative Expenses | 16.19 | 19.88 | 18.98 | 18.35 | 18.34 | 17.15 | 19.14 | 16.67 | 16.43 | |||||||||||
| Operating & Other expenses | 9.30 | 18.58 | 17.52 | 17.56 | 8.13 | 8.35 | 16.63 | 26.98 | 11.37 | |||||||||||
EBITDA | 8.72 | 82.32 | -4.58 | 13.49 | 13.61 | 21.11 | 38.14 | 58.56 | 20.29 | 14.73 | ||||||||||
| Depreciation/Amortization | 4.81 | 16.54 | 4.27 | 2.12 | 2.10 | 2.57 | 2.41 | 2.32 | 2.76 | 3.72 | ||||||||||
| PBIT | 3.91 | 65.78 | -8.85 | 11.37 | 11.51 | 18.54 | 35.73 | 56.24 | 17.53 | 11.01 | ||||||||||
| Interest & Other Items | 9.83 | 4.10 | 4.77 | 3.41 | 3.29 | 3.61 | 3.20 | 2.04 | 2.71 | 3.42 | ||||||||||
| PBT | -5.92 | 61.68 | -13.62 | 7.96 | 8.22 | 14.93 | 32.53 | 54.20 | 14.82 | 7.59 | ||||||||||
| Taxes & Other Items | 0.76 | 13.54 | 4.60 | 6.69 | 3.97 | 0.88 | 3.18 | 6.98 | 3.72 | 2.87 | ||||||||||
| Net Income | -6.68 | 48.14 | -18.22 | 1.27 | 4.25 | 14.05 | 29.35 | 47.22 | 11.10 | 4.72 | ||||||||||
| EPS | -0.87 | 6.28 | -2.38 | 0.17 | 0.55 | 1.83 | 3.83 | 6.16 | 1.45 | 0.62 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Ambalal Sarabhai Enterprises Ltd | 27.62 | 2.34 | — |
| Sun Pharmaceutical Industries Ltd | 35.10 | 5.01 | 0.93% |
| Cipla Ltd | 35.28 | 4.17 | 0.69% |
| Dr Reddy's Laboratories Ltd | 21.34 | 4.13 | 0.69% |
Price Comparison
Compare AMBALALSA with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Decreased Total Retail Holding
In last 3 months, retail holding in the company has decreased by 2.10%
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Shareholding History
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
AMBALALSA has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeNews & Opinions
News Video
Ambalal Sarabhai Enterprises के Mohal Sarabhai से खास बातचीत, जानें Company का Future Plan
2 years ago•CNBC Awaaz
Cosara Diagnostics gets CDSCO license to manufacture SARAGENE Dengue Test Kit
2 years ago•India Infoline
News Video
KYC में Ambalal Sarabhai Enterprises का Management, Company के नए Plan पर चर्चा | CNBC Awaaz
2 years ago•CNBC Awaaz
Ambalal Sarabhai Enterprises consolidated net profit rises 2760.22% in the June 2021 quarter
2 years ago•Business Standard
Ambalal Sarabhai Enterprises consolidated net profit rises 20.84% in the March 2021 quarter
2 years ago•Business Standard
Ambalal Sarabhai Enterprises reports standalone net loss of Rs 8.93 crore in the March 2021 quarter
2 years ago•Business Standard
Ambalal Sarabhai spurts after unit hikes production of Amphotericin B
2 years ago•Business Standard
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 4%, vs industry avg of 8.45%
Decreasing Market Share
Over the last 5 years, market share decreased from 0.07% to 0.06%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 54.28%, vs industry avg of 9.82%